{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35035508", "DateRevised": {"Year": "2024", "Month": "04", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "06"}], "Language": ["eng"], "ELocationID": ["7278731", "10.1155/2022/7278731"], "Journal": {"ISSN": "1741-427X", "JournalIssue": {"Volume": "2022", "PubDate": {"Year": "2022"}}, "Title": "Evidence-based complementary and alternative medicine : eCAM", "ISOAbbreviation": "Evid Based Complement Alternat Med"}, "ArticleTitle": "Structure-Based In Silico Investigation of Agonists for Proteins Involved in Breast Cancer.", "Pagination": {"StartPage": "7278731", "MedlinePgn": "7278731"}, "Abstract": {"AbstractText": ["Cancer is recognized as one of the main causes of mortality worldwide by the World Health Organization. The high cost of currently available cancer therapy and certain limitations of current treatment make it necessary to search for novel, cost-effective, and efficient methods of cancer treatment. Therefore, in the current investigation, sixty-two compounds from five medicinal plants (<i>Tinospora cordifolia, Ocimum tenuiflorum</i>, <i>Podophyllum hexandrum</i>, <i>Andrographis paniculata</i>, and <i>Beta vulgaris</i>) and two proteins that are associated with breast cancer, i.e., HER4/ErbB4 kinase and ER<i>\u03b1</i> were selected. Selected compounds were screened using Lipinski's rule, which resulted in eighteen molecules being ruled out. The remaining forty-four compounds were then taken forward for docking studies followed by molecular dynamics studies of the best screened complexes. Results showed that isocolumbin, isopropylideneandrographolide, and 14-acetylandrographolide were potential lead compounds against the selected breast cancer receptors. Furthermore, <i>in vitro</i> studies are required to confirm the efficacy of the lead compounds."], "CopyrightInformation": "Copyright \u00a9 2022 Arpita Roy et al."}, "AuthorList": [{"Identifier": ["0000-0002-1928-3093"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, School of Engineering & Technology, Sharda University, Greater Noida, India."}], "LastName": "Roy", "ForeName": "Arpita", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Delhi Technological University, Rohini, New Delhi, India."}], "LastName": "Anand", "ForeName": "Ashutosh", "Initials": "A"}, {"Identifier": ["0000-0001-9873-1095"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Delhi Technological University, Rohini, New Delhi, India."}], "LastName": "Garg", "ForeName": "Saksham", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, College of Sciences, King Saud University, Riyadh, Saudi Arabia."}], "LastName": "Khan", "ForeName": "Mohd Shahnawaz", "Initials": "MS"}, {"Identifier": ["0000-0002-4536-1649"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Indian Institute of Technology Delhi, Delhi, India."}], "LastName": "Bhasin", "ForeName": "Sidharth", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biology, University of Qu\u00e9bec at Trois-Rivieres, Trois-Rivieres, Qu\u00e9bec G9A 5H7, Canada."}], "LastName": "Asghar", "ForeName": "Muhammad Nadeem", "Initials": "MN"}, {"Identifier": ["0000-0003-3188-2272"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, BGC Trust University Bangladesh, Chittagong 4381, Bangladesh."}], "LastName": "Emran", "ForeName": "Talha Bin", "Initials": "TB"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Evid Based Complement Alternat Med", "NlmUniqueID": "101215021", "ISSNLinking": "1741-427X"}, "CoiStatement": "The authors declare that they have no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Polyak K. Heterogeneity in breast cancer. Journal of Clinical Investigation . 2011;121(10):3786\u20133788. doi: 10.1172/jci60534.", "ArticleIdList": ["10.1172/jci60534", "PMC3195489", "21965334"]}, {"Citation": "Datta S., Roy A. Antimicrobial peptides as potential therapeutic agents: a review. International Journal of Peptide Research and Therapeutics . 2021;27(1):555\u2013577. doi: 10.1007/s10989-020-10110-x.", "ArticleIdList": ["10.1007/s10989-020-10110-x"]}, {"Citation": "Shumway D. A., Sabolch A., Jagsi R. Breast cancer, Med. Radiol. 2020. pp. 1\u201343.", "ArticleIdList": ["10.1007/174_2016_83"]}, {"Citation": "Preventing cancer. April 2021.  \n https://www.who.int/activities/preventing-cancer\n."}, {"Citation": "Mohanty S. S., Sahoo C. R., Padhy R. N. Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: an update. Genes & Diseases. 2020.", "ArticleIdList": ["10.1016/j.gendis.2020.12.005", "PMC9243349", "35782984"]}, {"Citation": "Bondesson M., Hao R., Lin C.-Y., Williams C., Gustafsson J.-A. Estrogen receptor signaling during vertebrate development. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms . 2015;1849(2):142\u2013151. doi: 10.1016/j.bbagrm.2014.06.005.", "ArticleIdList": ["10.1016/j.bbagrm.2014.06.005", "PMC4269570", "24954179"]}, {"Citation": "Hewitt S. C., Couse J. F., Korach K. S. Estrogen receptor transcription and transactivation Estrogen receptor knockout mice: what their phenotypes reveal about mechanisms of estrogen action. Breast Cancer Research . 2000;2(5):p. 345. doi: 10.1186/bcr79.", "ArticleIdList": ["10.1186/bcr79", "PMC138656", "11250727"]}, {"Citation": "Paterni I., Granchi C., Katzenellenbogen J. A., Minutolo F. Estrogen receptors alpha (ER\u03b1) and beta (ER\u03b2): subtype-selective ligands and clinical potential. Steroids . 2014;90:13\u201329. doi: 10.1016/j.steroids.2014.06.012.", "ArticleIdList": ["10.1016/j.steroids.2014.06.012", "PMC4192010", "24971815"]}, {"Citation": "Warner M., Nilsson S., Gustafsson J.-A. The estrogen receptor family. Current Opinion in Obstetrics and Gynaecology . 1999;11(3):249\u2013254. doi: 10.1097/00001703-199906000-00003.", "ArticleIdList": ["10.1097/00001703-199906000-00003", "10369199"]}, {"Citation": "Lumachi F., Brunello A., Maruzzo M., Basso U., Basso S. Treatment of estrogen receptor-positive breast cancer. Current Medicinal Chemistry . 2013;20(5):596\u2013604. doi: 10.2174/092986713804999303.", "ArticleIdList": ["10.2174/092986713804999303", "23278394"]}, {"Citation": "Lumachi F. Current medical treatment of estrogen receptor-positive breast cancer. World Journal of Biological Chemistry . 2015;6(3):p. 231. doi: 10.4331/wjbc.v6.i3.231.", "ArticleIdList": ["10.4331/wjbc.v6.i3.231", "PMC4549764", "26322178"]}, {"Citation": "Olayioye M. A. NEW EMBO MEMBERS\u2019 REVIEW: the ErbB signaling network: receptor heterodimerization in development and cancer. The EMBO Journal . 2000;19(13):3159\u20133167. doi: 10.1093/emboj/19.13.3159.", "ArticleIdList": ["10.1093/emboj/19.13.3159", "PMC313958", "10880430"]}, {"Citation": "Wang J., Yin J., Yang Q., et al. Human epidermal growth factor receptor 4 (HER4) is a favorable prognostic marker of breast cancer: a systematic review and meta-analysis. Oncotarget . 2016;7(47):76693\u201376703. doi: 10.18632/oncotarget.12485.", "ArticleIdList": ["10.18632/oncotarget.12485", "PMC5363541", "27736797"]}, {"Citation": "M\u00e4\u00e4tt\u00e4 J. A., Sundvall M., Junttila T. T., et al. Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth. Molecular Biology of the Cell . 2006;17(1):67\u201379. doi: 10.1091/mbc.e05-05-0402.", "ArticleIdList": ["10.1091/mbc.e05-05-0402", "PMC1345647", "16251361"]}, {"Citation": "Junttila T. T., Sundvall M., Lundin M., et al. Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells. Cancer Research . 2005;65(4):1384\u20131393. doi: 10.1158/0008-5472.can-04-3150.", "ArticleIdList": ["10.1158/0008-5472.can-04-3150", "15735025"]}, {"Citation": "Zhu Y., Sullivan L. L., Nair S. S., et al. Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells. Cancer Research . 2006;66(16):7991\u20137998. doi: 10.1158/0008-5472.can-05-4397.", "ArticleIdList": ["10.1158/0008-5472.can-05-4397", "16912174"]}, {"Citation": "Muraoka-Cook R. S., Caskey L. S., Sandahl M. A., et al. Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1. Molecular and Cellular Biology . 2006;26(17):6412\u20136424. doi: 10.1128/mcb.01950-05.", "ArticleIdList": ["10.1128/mcb.01950-05", "PMC1592831", "16914727"]}, {"Citation": "Smaill J. B., Rewcastle G. W., Loo J. A., et al. Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(Phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions. Journal of Medicinal Chemistry . 2000;43(7):1380\u20131397. doi: 10.1021/jm990482t.", "ArticleIdList": ["10.1021/jm990482t", "10753475"]}, {"Citation": "De Pauw I., Wouters A., Van den Bossche J., et al. Preclinical and clinical studies on afatinib in monotherapy and in combination regimens: potential impact in colorectal cancer. Pharmacology & Therapeutics . 2016;166:71\u201383. doi: 10.1016/j.pharmthera.2016.06.014.", "ArticleIdList": ["10.1016/j.pharmthera.2016.06.014", "27373506"]}, {"Citation": "Roy A., Bharadvaja N. Venom-derived bioactive compounds as potential anticancer agents: a review. International Journal of Peptide Research and Therapeutics . 2021;27(1):129\u2013147. doi: 10.1007/s10989-020-10073-z.", "ArticleIdList": ["10.1007/s10989-020-10073-z"]}, {"Citation": "Garg S., Anand A., Lamba Y., Roy A. Molecular docking analysis of selected phytochemicals against SARS-CoV-2 Mpro receptor. Vegetos . 2020;33(4):766\u2013781. doi: 10.1007/s42535-020-00162-1.", "ArticleIdList": ["10.1007/s42535-020-00162-1", "PMC7567421", "33100613"]}, {"Citation": "Roy A., Jauhari N., Bharadvaja N. Anticancer Plants: Natural Products and Biotechnological Implements . Singapore: Springer; 2018. Medicinal plants as a potential source of chemopreventive agents; pp. 109\u2013139."}, {"Citation": "Roy A., Bharadvaja N. Medicinal plants in the management of cancer: a review. International Journal of Complementary & Alternative Medicine . 2017;9(2):p. 00291."}, {"Citation": "Roy A. Plumbagin: a potential anti-cancer compound. Mini Reviews in Medicinal Chemistry . 2020", "ArticleIdList": ["33200707"]}, {"Citation": "Roy A., Ahuja S., Bharadvaja N. A review on medicinal plants against cancer. Journal of Plant Sciences and Agricultural Research . 2017;2:p. 1008."}, {"Citation": "Roy A., Attre T., Bharadvaja N., Tiezzi A., Karpi\u0144ski T. M. Anticancer agent from medicinal plants: a review. New apects in medicinal plants and pharmacognosy . 2017;1:p. 54."}, {"Citation": "Roy A., Bharadvaja N. A review on pharmaceutically important medical plant: plumbago zeylanica. Journal of Ayurveda and Holistic Medicine . 2017;3(4):225\u2013228."}, {"Citation": "Roy A., Bharadvaja N. Centella asiatica: a pharmaceutically important medicinal plant. Current Trends in Biomedical Engineering & Biosciences . 2017;5(3):1\u20135."}, {"Citation": "Berman H. M., Westbrook J., Feng Z., et al. The protein data bank. Nucleic Acids Research . 2000;28(1):235\u2013242.", "ArticleIdList": ["PMC102472", "10592235"]}, {"Citation": "Kim S., Thiessen P. A., Bolton E. E., et al. PubChem substance and compound databases. Nucleic Acids Research . 2016;44(D1):D1202\u2013D1213.", "ArticleIdList": ["PMC4702940", "26400175"]}, {"Citation": "Sahoo C. R., Paidesetty S. K., Padhy R. N. Nostocine A derivatives as human DNA topoisomerase II-alpha inhibitor. Indian Journal of Pharmaceutical Education and Research . 2020;54(3):669\u2013675. doi: 10.5530/ijper.54.3.120.", "ArticleIdList": ["10.5530/ijper.54.3.120"]}, {"Citation": "Daina A., Michielin O., Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports . 2017;7(1):p. 42717. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Lipinski C. A. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technologies . 2004;1(4):337\u2013341. doi: 10.1016/j.ddtec.2004.11.007.", "ArticleIdList": ["10.1016/j.ddtec.2004.11.007", "24981612"]}, {"Citation": "Sahoo C. R., Paidesetty S. K., Sarathbabu S., Dehury B., Senthil Kumar N., Padhy R. N. Molecular dynamics simulation, synthesis and topoisomerase inhibitory actions of vanillin derivatives: a systematic computational structural integument. Journal of Biomolecular Structure and Dynamics . 2021:1\u201311.", "ArticleIdList": ["34355674"]}, {"Citation": "User Manual, Impact 6.7, Schr\u00f6dinger . 2015."}, {"Citation": "Bhatia K. S., Garg S., Anand A., Roy A. Evaluation of different phytochemicals against BRCA2 receptor. Biointerface Research in Applied Chemistry . 2021;2022(12):1670\u20131681. doi: 10.33263/BRIAC122.16701681.", "ArticleIdList": ["10.33263/BRIAC122.16701681"]}, {"Citation": "Garg S., Roy A. In silico analysis of selected alkaloids against main protease (Mpro) of SARS-CoV-2. Chemico-Biological Interactions . 2020;332:p. 109309. doi: 10.1016/j.cbi.2020.109309.", "ArticleIdList": ["10.1016/j.cbi.2020.109309", "PMC7649659", "33181114"]}, {"Citation": "Garg S., Anand A., Lamba Y., Roy A. Molecular docking analysis of selected phytochemicals against SARS-CoV-2 Mpro receptor. Vegetos . 2020;33(4):766\u2013781. doi: 10.1007/s42535-020-00162-1.", "ArticleIdList": ["10.1007/s42535-020-00162-1", "PMC7567421", "33100613"]}, {"Citation": "Kapadia G. J., Azuine M. A., Subba Rao G., Arai T., Iida A., Tokuda H. Cytotoxic effect of the red beetroot (Beta vulgaris L.) extract compared to doxorubicin (adriamycin) in the human prostate (PC-3) and breast (MCF-7) cancer cell lines. Anti-Cancer Agents in Medicinal Chemistry . 2011;11(3):280\u2013284. doi: 10.2174/187152011795347504.", "ArticleIdList": ["10.2174/187152011795347504", "21434853"]}, {"Citation": "Lechner J. F., Wang L.-S., Rocha C. M., et al. Drinking water with red beetroot food color antagonizes esophageal carcinogenesis in N-Nitrosomethylbenzylamine-Treated rats. Journal of Medicinal Food . 2010;13(3):733\u2013739. doi: 10.1089/jmf.2008.0280.", "ArticleIdList": ["10.1089/jmf.2008.0280", "PMC3133561", "20438319"]}, {"Citation": "Kapadia G. Chemoprevention of DMBA-induced UV-B promoted, NOR-1-induced TPA promoted skin carcinogenesis, and DEN-induced phenobarbital promoted liver tumors in mice by extract of beetroot. Pharmacological Research . 2003;47(2):141\u2013148. doi: 10.1016/s1043-6618(02)00285-2.", "ArticleIdList": ["10.1016/s1043-6618(02)00285-2", "12543062"]}, {"Citation": "Harsha M., Mohan Kumar K., Kagathur S., Amberkar V. Effect of Ocimum sanctum extract on leukemic cell lines: a preliminary in-vitro study. Journal of Oral and Maxillofacial Forest Pathology . 2020;24:p. 93.", "ArticleIdList": ["PMC7269281", "32508455"]}, {"Citation": "Palmieri A., Scapoli L., Iapichino A., et al. Berberine and Tinospora cordifolia exert a potential anticancer effect on colon cancer cells by acting on specific pathways. International Journal of Immunopathology & Pharmacology . 2019;33 doi: 10.1177/2058738419855567.", "ArticleIdList": ["10.1177/2058738419855567", "PMC6822188", "31663444"]}, {"Citation": "Ahmad M. S., Ahmad S., Arshad M., Afzal M. Andrographia paniculata a Miracle Herbs for cancer treatment: in vivo and in vitro studies against Aflatoxin B1 Toxicity. Egyptian Journal of Medical Human Genetics . 2014;15(2):163\u2013171. doi: 10.1016/j.ejmhg.2013.12.006.", "ArticleIdList": ["10.1016/j.ejmhg.2013.12.006"]}, {"Citation": "Singh S., Mehta A., Baweja S., Ahirwal L., Mehta P. Anticancer activity of Andrographis paniculata and Silybum marianum on five human cancer cell lines. Journal of Pharmacology and Toxicology . 2012;8(1):42\u201348. doi: 10.3923/jpt.2013.42.48.", "ArticleIdList": ["10.3923/jpt.2013.42.48"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "13"}, {"Year": "2021", "Month": "12", "Day": "21"}, {"Year": "2021", "Month": "12", "Day": "23"}, {"Year": "2022", "Month": "1", "Day": "17", "Hour": "5", "Minute": "55"}, {"Year": "2022", "Month": "1", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "18", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "1", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["35035508", "PMC8758269", "10.1155/2022/7278731"]}}], "PubmedBookArticle": []}